Ragnhild Reehorst Lereim

Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial

Andreas Hagen Røssevold, Nikolai Kragøe Andresen, Christina Bjerre et al. · Nature Medicine · 2022 · 81 citations · Full text

Medicine, Oncology, Pharmacology +17

CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders

Astrid Guldbrandsen, Yehia Farag, Ann Cathrine Kroksveen et al. · Molecular & Cellular Proteomics · 2016 · 48 citations · Full text

Life Sciences, Neurology, Neuroscience +15

In-Depth Cerebrospinal Fluid Quantitative Proteome and Deglycoproteome Analysis: Presenting a Comprehensive Picture of Pathways and Processes Affected by Multiple Sclerosis

Ann Cathrine Kroksveen, Astrid Guldbrandsen, Marc Vaudel et al. · Journal of Proteome Research · 2016 · 43 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis

Eystein Oveland, Intakhar Ahmad, Ragnhild Reehorst Lereim et al. · Scientific Reports · 2021 · 34 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model

Agnes E. Nystad, Ragnhild Reehorst Lereim, Stig Wergeland et al. · Journal of Neuroimmunology · 2019 · 24 citations · Full text

Medicine, Neuroscience, Pharmacology +14